Digital How GenAI is cracking the toughest targets in drug discovery Generative AI has the potential to solve for designing effective antibodies for G‑protein coupled receptors (GPCRs).
News After failure in sickle cell, Fulcrum merges with Slate Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
